| 1. |
Short-term clopidogrel recommended by UK NICE |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
Infliximab, etanercept worthwhile for RA in Spain? |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 3-3
&NA;,
Preview
|
|
摘要:
Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes pain, swelling and stiffness in peripheral joints. RA is one of the most debilitating forms of arthritis, with joint destruction and bone erosion a hallmark of the disease. Indeed, in advanced stages, RA can be crippling, and require lifelong treatment and often surgery. While there is no cure for the disease, drug treatment can help to reduce pain and inflammation, and slow the progression of joint damage. Due to its chronic nature and the potential for disability, RA is associated with high healthcare resource use and costs. In Spain, the annual cost attributable to RA has been estimated at euro1 billion−euro2 billion. Consequently, therapies that can treat patients with RA in a cost-effective manner are important. Two studies which examined the cost effectiveness of RA treatments in Spain were presented at a poster session at the Annual European Congress of Rheumatology (EULAR) [Berlin, Germany; June 2004].
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
New global malaria initiative supports artemisinin-based therapy |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
WHO's '3 by 5' HIV/AIDS strategy strengthened by criticism |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Epilepsy accounts for increased costs in Burundi |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
Ciclosporin monitoring: 2-hour post-dose strategy cost saving |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
Identifying issues and improving care in migraine |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Bicalutamide as adjuvant therapy warranted in early prostate cancer |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
The treatment costs for community-acquired pneumonia (CAP) in an employed US population are"substantially higher" |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Value of nevirapine for preventing MTCT of HIV infections in Africa |
| |
PharmacoEconomics & Outcomes News,
Volume &NA;,
Issue 459,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
